323 related articles for article (PubMed ID: 27327261)
1. Alzheimer's disease, menopause and the impact of the estrogenic environment.
Pines A
Climacteric; 2016 Oct; 19(5):430-2. PubMed ID: 27327261
[TBL] [Abstract][Full Text] [Related]
2. The Women's Health Initiative Study of Cognitive Aging (WHISCA): a randomized clinical trial of the effects of hormone therapy on age-associated cognitive decline.
Resnick SM; Coker LH; Maki PM; Rapp SR; Espeland MA; Shumaker SA
Clin Trials; 2004; 1(5):440-50. PubMed ID: 16279282
[TBL] [Abstract][Full Text] [Related]
3. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.
Rapp SR; Espeland MA; Shumaker SA; Henderson VW; Brunner RL; Manson JE; Gass ML; Stefanick ML; Lane DS; Hays J; Johnson KC; Coker LH; Dailey M; Bowen D;
JAMA; 2003 May; 289(20):2663-72. PubMed ID: 12771113
[TBL] [Abstract][Full Text] [Related]
4. Hormone therapy, dementia, and cognition: the Women's Health Initiative 10 years on.
Maki PM; Henderson VW
Climacteric; 2012 Jun; 15(3):256-62. PubMed ID: 22612612
[TBL] [Abstract][Full Text] [Related]
5. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
Brinton RD
Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
[TBL] [Abstract][Full Text] [Related]
6. Surgical menopause and cognitive decline.
Pines A
Climacteric; 2014 Oct; 17(5):580-2. PubMed ID: 24502814
[TBL] [Abstract][Full Text] [Related]
7. The rationale, design, and baseline characteristics of the Women's Health Initiative Memory Study of Younger Women (WHIMS-Y).
Vaughan L; Espeland MA; Snively B; Shumaker SA; Rapp SR; Shupe J; Robinson JG; Sarto GE; Resnick SM;
Brain Res; 2013 Jun; 1514():3-11. PubMed ID: 23578696
[TBL] [Abstract][Full Text] [Related]
8. Surgical menopause, estrogen, and cognitive function in women: what do the findings tell us?
Sherwin BB
Ann N Y Acad Sci; 2005 Jun; 1052():3-10. PubMed ID: 16024746
[TBL] [Abstract][Full Text] [Related]
9. The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.
Gurney EP; Nachtigall MJ; Nachtigall LE; Naftolin F
J Steroid Biochem Mol Biol; 2014 Jul; 142():4-11. PubMed ID: 24172877
[TBL] [Abstract][Full Text] [Related]
10. Effects of combination estrogen plus progestin hormone treatment on cognition and affect.
Resnick SM; Maki PM; Rapp SR; Espeland MA; Brunner R; Coker LH; Granek IA; Hogan P; Ockene JK; Shumaker SA;
J Clin Endocrinol Metab; 2006 May; 91(5):1802-10. PubMed ID: 16522699
[TBL] [Abstract][Full Text] [Related]
11. Action of estrogens in the aging brain: dementia and cognitive aging.
Henderson VW
Biochim Biophys Acta; 2010 Oct; 1800(10):1077-83. PubMed ID: 19913598
[TBL] [Abstract][Full Text] [Related]
12. Postmenopausal hormone therapy and cognition.
McCarrey AC; Resnick SM
Horm Behav; 2015 Aug; 74():167-72. PubMed ID: 25935728
[TBL] [Abstract][Full Text] [Related]
13. The Women's Health Initiative Memory Study: findings and implications for treatment.
Craig MC; Maki PM; Murphy DG
Lancet Neurol; 2005 Mar; 4(3):190-4. PubMed ID: 15721829
[TBL] [Abstract][Full Text] [Related]
14. Menopause and mitochondria: windows into estrogen effects on Alzheimer's disease risk and therapy.
Henderson VW; Brinton RD
Prog Brain Res; 2010; 182():77-96. PubMed ID: 20541661
[TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacology and differential cognitive efficacy of estrogen preparations.
Gleason CE; Carlsson CM; Johnson S; Atwood C; Asthana S
Ann N Y Acad Sci; 2005 Jun; 1052():93-115. PubMed ID: 16024754
[TBL] [Abstract][Full Text] [Related]
16. The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms.
Parish SJ; Gillespie JA
Postgrad Med; 2017 Apr; 129(3):340-351. PubMed ID: 28132583
[TBL] [Abstract][Full Text] [Related]
17. The Women's Health Initiative conundrum.
Birkhaeuser MH
Arch Womens Ment Health; 2005 May; 8(1):7-14. PubMed ID: 15895190
[TBL] [Abstract][Full Text] [Related]
18. Minireview: effects of different HT formulations on cognition.
Maki PM
Endocrinology; 2012 Aug; 153(8):3564-70. PubMed ID: 22673228
[TBL] [Abstract][Full Text] [Related]
19. Postmenopausal hormone therapy and cognitive outcomes: the Women's Health Initiative Memory Study (WHIMS).
Coker LH; Espeland MA; Rapp SR; Legault C; Resnick SM; Hogan P; Gaussoin S; Dailey M; Shumaker SA
J Steroid Biochem Mol Biol; 2010 Feb; 118(4-5):304-10. PubMed ID: 19932751
[TBL] [Abstract][Full Text] [Related]
20. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study.
Espeland MA; Rapp SR; Shumaker SA; Brunner R; Manson JE; Sherwin BB; Hsia J; Margolis KL; Hogan PE; Wallace R; Dailey M; Freeman R; Hays J;
JAMA; 2004 Jun; 291(24):2959-68. PubMed ID: 15213207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
